These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Safety and immunologic effectiveness of polyantigen from shigellae for oral immunization of monkeys]. Dzhikidze EK; Kavtaradze KN; Raush K; Ketii I; Krasnoproshina LI Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):73-8. PubMed ID: 413291 [TBL] [Abstract][Full Text] [Related]
11. [Humoral and cellular immunity in patients with acute dysentery]. Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054 [No Abstract] [Full Text] [Related]
12. [New directions in the study of immunity in dysentery]. Pokrovskiĭ VI; Godovannyĭ BA; Iushchuk ND Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):6-12. PubMed ID: 6346759 [No Abstract] [Full Text] [Related]
13. Immunity against dysentery after enteral immunization with live vaccine. Denchev V; Trifonova A; Jeleva M; Duncheva S; Bratanova V; Dimitrova Z; Kovachev P Acta Microbiol Acad Sci Hung; 1974; 21(1-2):71-4. PubMed ID: 4613140 [No Abstract] [Full Text] [Related]
14. Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin. Kowalewska D; Mulczyk M Acta Microbiol Acad Sci Hung; 1974; 21(1-2):99-102. PubMed ID: 4613143 [No Abstract] [Full Text] [Related]
15. Technological aspect of the production of live dysentery vaccines for oral administration. Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499 [TBL] [Abstract][Full Text] [Related]
16. Protective milk O antibodies induced in guinea pigs by parenteral Shigella ribosomal vaccine. Chernokhvostova EV; Lyubinskaya MM; Belkin ZP; Levenson VI Int Arch Allergy Appl Immunol; 1990; 92(3):265-7. PubMed ID: 2276843 [TBL] [Abstract][Full Text] [Related]
17. Local and systemic antibody responses to Shigella infection in rhesus monkeys. Dinari G; Hale TL; Austin SW; Formal SB J Infect Dis; 1987 May; 155(5):1065-9. PubMed ID: 3549918 [No Abstract] [Full Text] [Related]
18. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children. Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R; Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770 [TBL] [Abstract][Full Text] [Related]
19. Studies on specificity of protection induced by immunization with outer membrane proteins of Shigella. Witkowska D; Mulczyk M; Adamus G Arch Immunol Ther Exp (Warsz); 1985; 33(5):625-8. PubMed ID: 3914866 [TBL] [Abstract][Full Text] [Related]
20. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose. Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128 [No Abstract] [Full Text] [Related] [Next] [New Search]